Exec Edge hold a fireside chat in the ICR 2025 Conference with Michel BroussetCEO of Waldencast plc (Nasdaq: WALD). Tit was his personal interview joined by Editor-at-Large Jarrett Banks and they discussed the marketing differences between Milk Makeup and Obagi Medical, the company's strategies to drive organic growth, and more.
Watch the full recording:
About Michel Brousset
Michel Brousset has more than 25 years of experience leading, operating and building global brands at L'Oréal (PAR: OR) and Procter & Gamble (NYSE: PG) where he worked to launch and build iconic brands on across multiple geographies. Most recently, Mr Brousset founded Waldencast, a holding company and investment vehicle, in 2019 and has been CEO since its inception. Waldencast partners and creates next generation beauty and wellness brands, collaborating with a variety of founders from diverse backgrounds (across three continents, 56% female) and recruiting and attracting skilled beauty and wellness talent. In 2022, Waldencast plc was publicly listed on the Nasdaq, with Milk Makeup and Obagi becoming part of the portfolio company led by Mr Brousset.
About Waldencast
Founded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a best-in-class global beauty and wellness operating platform by developing, acquiring, accelerating and scaling purpose-built, high-growth conscious brands. Waldencast's vision is fundamentally based on its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand's unique DNA. The first step in realizing his vision was the business combination with Obagi Skincare and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands.
Contact: